Should patients with drug-resistant HIV-1 continue to receive antiretroviral therapy?

被引：9
|
作者：
Frenkel, LM [1 ]
Mullins, JI
机构：
[1] Univ Washington, Sch Med, Seattle, WA 98105 USA
[2] Univ Washington, Sch Med, Seattle, WA 98195 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2001年 / 344卷 / 07期
关键词：
D O I：
10.1056/NEJM200102153440710
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：520 / 522
页数：3
相关论文
共 50 条
  • [41] Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapy
    Poveda, Eva
    Briz, Veronica
    Paraskevis, Dimitrios
    Barreiro, Pablo
    Hatzakis, Angelos
    Soriano, Vincent
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (09) : 1078 - 1082
  • [42] Efficient Suppression of Minority Drug-Resistant HIV Type 1 (HIV-1) Variants Present at Primary HIV-1 Infection by Ritonavir-Boosted Protease Inhibitor-Containing Antiretroviral Therapy
    Metzner, Karin J.
    Rauch, Pia
    von Wyl, Viktor
    Leemann, Christine
    Grube, Christina
    Kuster, Herbert
    Boeni, Juerg
    Weber, Rainer
    Guenthard, Huldrych F.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (07): : 1063 - 1071
  • [43] Confronting the emergence of drug-resistant HIV type 1: Impact of antiretroviral therapy on individual and population resistance
    Daar, ES
    Richman, DD
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (05) : 343 - 357
  • [44] Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy
    Antinori, A
    Liuzzi, G
    Cingolani, A
    Bertoli, A
    Di Giambenedetto, S
    Trotta, MP
    Rizzo, MG
    Girardi, E
    De Luca, A
    Perno, CF
    AIDS, 2001, 15 (17) : 2325 - 2327
  • [45] HIV-1 superinfection with a triple-class drug-resistant strain in a patient successfully controlled with antiretroviral treatment
    Castro, Erika
    Zhao, Hong
    Cavassini, Matthias
    Mullins, James I.
    Pantaleo, Giuseppe
    Bart, Pierre-Alexandre
    AIDS, 2014, 28 (12) : 1840 - 1844
  • [46] Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development
    Palmer, S
    Shafer, RW
    Merigan, TC
    AIDS, 1999, 13 (06) : 661 - 667
  • [47] Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure
    Paredes, Roger
    Lalama, Christina M.
    Ribaudo, Heather J.
    Schackman, Bruce R.
    Shikuma, Cecilia
    Giguel, Francoise
    Meyer, William A., III
    Johnson, Victoria A.
    Fiscus, Susan A.
    D'Aquila, Richard T.
    Gulick, Roy M.
    Kuritzkes, Daniel R.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (05): : 662 - 671
  • [48] Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions
    Schweighardt, B
    Ortiz, GM
    Grant, RM
    Wellons, M
    Miralles, GD
    Kostrikis, LG
    Bartlett, JA
    Nixon, DF
    AIDS, 2002, 16 (17) : 2342 - 2344
  • [49] Emergence of HIV-1 drug-resistant variants in women following antiretroviral prophylaxis for the prevention of mother to child transmission
    Mani, M.
    Ramalingam, V. V.
    Lionel, J.
    Christina, S. A.
    Sachithanandham, J.
    Peedicayil, A.
    Kannangai, R.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 33 (02) : 225 - 230
  • [50] HIV drug resistant mutations in HIV-1 subtype C children failing antiretroviral therapy in South Africa
    Wallis, C. L.
    Varughese, S.
    Technau, K.
    Stevens, W.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A184 - A184
12345